PL
Therapeutic Areas
Leman Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Meta10-19 | Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1/2 |
| Meta10-BCMA CAR-T | Relapsed/Refractory Plasma Cell Neoplasms | Phase 1 |
| Meta10-TILs | Advanced Solid Tumors | Phase 1 |